Project Grant R21NS153280
- The National Institute of Neurological Disorders and Stroke awarded Emory University $234,750 on January 26, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate neuromodulation of somato-sympathetic postganglionic activity after spinal cord injury. The research develops animal models incorporating clinically analogous epidural spinal cord stimulation to understand how neuromodulation can restore autonomic function...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $547,750 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate human-specific mechanisms governing miR-124 regulation of neuronal development. The research focuses on microRNA biogenesis and function in the human brain, specifically examining how miR-124—the most abundant microRNA in brain tissue—controls spatiotemporal...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $534,557 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of Renshaw cells and recurrent inhibition during motor behaviors. The research examines how Renshaw cells—inhibitory interneurons within the spinal cord's output-regulating microcircuit—contribute to coordinated limb movements and motor control in...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $234,750 on May 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate NMDA receptor regulation of rapid synaptic scaling and spinal excitability in fragile X syndrome. The research will identify mechanisms controlling maturation of network excitability during neonatal development, with focus on how NMDA receptor blockade triggers...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $460,839 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to cultivate rigor in movement neuroscience research by aligning professional incentives with rigorous study design practices. Emory will establish community-focused programs to address the reproducibility crisis in movement neuroscience by creating incentives that...
- Federal Grant Award Summary Emory University received a $430,375 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025 through June 30, 2027. The award funds research to elucidate the mechanisms of altered RNA transport dynamics caused by KIF1C (Kinesin-3 motor protein) mutations in heterospastic paraplegia type 58 (SPG58), a...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $575,485 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the role of the BCL11A gene in neuron function and neurological disease. The award funds research examining how BCL11A, a zinc-finger transcription factor, contributes to intellectual disability, autism spectrum disorder, epilepsy, schizophrenia, and...
- The National Institute of Neurological Disorders and Stroke awarded Emory University $149,190 on July 26, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct functional and biochemical analysis of RNA exosome variants linked to neurological disorders. The award funds research analyzing missense mutations in the EXOSC5 subunit of the RNA exosome complex to understand how each mutation alters RNA exosome function and leads...
- The National Institute of Neurological Disorders and Stroke awarded The Johns Hopkins University $232,938 on February 17, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to generate critical knowledge on neuronal membrane proteasome-derived peptide signaling in the peripheral nervous system. The research extends prior work on NMP-peptides and their role in peripheral neuron crosstalk and regulation. The award funds proteomics,...
- The National Institute of Neurological Disorders and Stroke awarded $427,625 to the University of Washington on May 19, 2026, to identify axon length-dependent gene expression programs and their role in neurodegenerative disease vulnerability under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders. The recipient will systematically identify genes whose expression levels covary with axon length and characterize their functional roles in length-dependent...
The National Institute of Neurological Disorders and Stroke awarded Emory University $428,218 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop subcellularly resolved spatial genomics approaches for studying axon regeneration. The research maps the nerve regenerative landscape by building a three-dimensional spatial single-cell transcriptomics atlas of dorsal root ganglia in mice, training a morphology-based classifier of neuronal subtypes, and engineering a soma-axon-matched barcoding system to directly link transcriptional reprogramming at the cell body to local regenerative phenotypes at axonal injury sites. The work addresses key barriers in understanding why peripheral nervous system neurons regenerate more robustly than central nervous system neurons despite the challenges posed by the physical distance between injury sites and soma, and why functional recovery in patients remains incomplete. Performance occurs at Emory University's Atlanta, Georgia location through August 31, 2028. The award is classified as a Project Grant under the R21 mechanism, supporting early-stage exploratory research that seeks fundamental knowledge about the brain and nervous system to reduce the burden of neurological disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $428.2k | 9/1/26 |